Outlook Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Outlook Therapeutics, Inc. is a biopharmaceutical company developing therapies for retinal diseases. The company focuses on ONS-5010, a formulation of bevacizumab for intravitreal injection to treat wet age-related macular degeneration and other retinal conditions. Outlook Therapeutics aims to provide ophthalmic treatments that improve outcomes for patients with vision-threatening diseases.